Table 3.
Vesicular System | Payload | Phase of Study | Clinical Trial Identifier | Sponsor |
---|---|---|---|---|
Liposome | Irinotecan and Bevacizumab | I | NCT05854498 | University of Wisconsin (Madison, WI, USA) |
Irinotecan-based FOLFIRI combined with Bevacizumab | II | NCT05969899 | Fudan University (Shanghai, China) | |
Fluorouracil and Irinotecan and Leucovorin | I, II | NCT03337087 | Academic and Community Cancer Research United (Rochester, MN, USA) | |
Polymeric nanoparticle | Cetuximab | I | NCT03774680 | Al-Azhar University (Cairo, Egypt) |